Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report

• Jessica D. St. Laurent,
• Mary Kathryn Abel,
• Joyce Liu,
• Bradley J. Quade,
• Michelle R. Davis

Affiliations

Jessica D. St. Laurent

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA

Mary Kathryn Abel

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA

Joyce Liu

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA

Bradley J. Quade

Division of Women’s and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Michelle R. Davis

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA; Corresponding author at: Division of Gynecologic Oncology, Brigham and Women’s Hospital, 75 Francis St. ASB1 3rd Floor, Boston, MA 02115, USA.